Lakatos László, Lakatos Péter László
Csolnoky Ferenc Megyei Kórház, Belgyógyászati Centrum, Veszprém, Kórház u. 1. 8200.
Orv Hetil. 2010 May 23;151(21):870-7. doi: 10.1556/OH.2010.28868.
Crohn's disease is a chronic, progressive disabling condition ultimately leading to stricturing and/or penetrating complications. The need for surgery may be as high as 70% in patients with severe active disease or complications. However, relapse may develop in a significant proportion of the patients after surgery leading to frequent re-operations. Despite emerging data, postoperative prevention is still controversial. After careful evaluation of the individual risk a tailored therapy should be considered. In patients with small risk for relapse mesalazine or in selected cases no-treatment may be an option. In patients with a moderate-to-high risk azathioprine should be considered together with metronidazole in the three months. Follow-up ileocolonoscopy 6-12 months after the surgery is helpful in the determination of endoscopic severity and may assist in the optimization of the therapy. In most severe cases anti-TNF agents may be appropriate for postoperative prevention and therapy.
克罗恩病是一种慢性、进行性致残性疾病,最终会导致狭窄和/或穿透性并发症。重症活动性疾病或有并发症的患者手术需求可能高达70%。然而,相当一部分患者术后可能复发,导致频繁再次手术。尽管有新的数据出现,但术后预防仍存在争议。仔细评估个体风险后,应考虑采用个性化治疗。复发风险低的患者可选用美沙拉嗪,或在某些特定情况下可不治疗。复发风险中到高的患者,应考虑使用硫唑嘌呤,并在三个月内联合甲硝唑治疗。术后6 - 12个月进行随访性回结肠镜检查,有助于确定内镜严重程度,并可能有助于优化治疗方案。在大多数严重病例中,抗TNF药物可能适用于术后预防和治疗。